TY - JOUR
T1 - Bone Marrow Transplantation and Cataract Development
AU - Dunn, James P.
AU - Jabs, Douglas A.
AU - Wingard, John
AU - Enger, Cheryl
AU - Vogelsang, Georgia
AU - Santos, George
N1 - Funding Information:
AcceptedforpublicationJune16, 1993. This study was supported in part by grants EY01765fromtheNationalEyeInstituteand CA15396 from the National Cancer Institute, NationalInstitutes of Health, Bethesda, Md. Dr JabsisaResearchtoPreventBlindnessOlgaKeith
PY - 1993/10
Y1 - 1993/10
N2 - To evaluate risk factors for the development of posterior subcapsular cataract following bone marrow transplantation (BMT) and the results of patients undergoing cataract extraction. Retrospective case-control study. Tertiary referral center. Three hundred sixty-six patients (59% male, 41% female) undergoing BMT at one institution who survived for at least 1 month and underwent full ophthalmologic examination. Risk factors were then compared between patients who developed posterior subcapsular cataract and those who did not. Cataract surgery in six eyes of four patients. Formation of posterior subcapsular cataract. Data were obtained on all patients for type of BMT, pretransplantation regimen, underlying malignancy, demographic background, complications of BMT, and medications. Forty (10.9%) of 366 patients developed posterior subcapsular cataract. By univariate analysis, cataract formation was associated with total body irradiation, chronic graft-vs-host disease, the use of allogeneic bone marrow, and the total dose and duration of corticosteroid therapy. Multivariate analysis revealed that the total dose and duration of corticosteroid therapy were the most important risk factors, while total body irradiation was not a statistically significant risk factor. Cataract surgery was performed in six eyes of four patients, all of whom developed visual acuities of 20/40 or better. Posterior subcapsular cataract following BMT is uncommon and rarely requires surgery. Total dose and duration of corticosteroid therapy are the most important risk factors for development of cataract, but total body irradiation is not a statistically significant risk factor.
AB - To evaluate risk factors for the development of posterior subcapsular cataract following bone marrow transplantation (BMT) and the results of patients undergoing cataract extraction. Retrospective case-control study. Tertiary referral center. Three hundred sixty-six patients (59% male, 41% female) undergoing BMT at one institution who survived for at least 1 month and underwent full ophthalmologic examination. Risk factors were then compared between patients who developed posterior subcapsular cataract and those who did not. Cataract surgery in six eyes of four patients. Formation of posterior subcapsular cataract. Data were obtained on all patients for type of BMT, pretransplantation regimen, underlying malignancy, demographic background, complications of BMT, and medications. Forty (10.9%) of 366 patients developed posterior subcapsular cataract. By univariate analysis, cataract formation was associated with total body irradiation, chronic graft-vs-host disease, the use of allogeneic bone marrow, and the total dose and duration of corticosteroid therapy. Multivariate analysis revealed that the total dose and duration of corticosteroid therapy were the most important risk factors, while total body irradiation was not a statistically significant risk factor. Cataract surgery was performed in six eyes of four patients, all of whom developed visual acuities of 20/40 or better. Posterior subcapsular cataract following BMT is uncommon and rarely requires surgery. Total dose and duration of corticosteroid therapy are the most important risk factors for development of cataract, but total body irradiation is not a statistically significant risk factor.
UR - http://www.scopus.com/inward/record.url?scp=0027431488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027431488&partnerID=8YFLogxK
U2 - 10.1001/archopht.1993.01090100075031
DO - 10.1001/archopht.1993.01090100075031
M3 - Article
C2 - 8216017
AN - SCOPUS:0027431488
SN - 2168-6165
VL - 111
SP - 1367
EP - 1373
JO - JAMA Ophthalmology
JF - JAMA Ophthalmology
IS - 10
ER -